Latest News and Press Releases

Q1 2023/24Interim financial results, Q1 2023/241 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin1) of 28%. Reported...

Selskabet sigter efter at udvide sin position inden for avanceret sårbehandling ved at introducere en ny sårbandage, der gavner både sundhedspersonale og patienter. ”Vi introducerer nu dette nye...

The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and patients. “We are now introducing new...

Friday, 9 February 2024 at 11.00 - 12.00 CETIn connection with the publication of Coloplast’s interim financial results for Q1 2023/24, to be released same day around 07.30 am CET, Coloplast will host...

I dag, den 7. december 2023, har Coloplast A/S afholdt ordinær generalforsamling, hvor EY Godkendt Revisionspartnerselskab blev valgt som Coloplast A/S’ revisor i overensstemmelse med forslaget fra...

Today, 7 December 2023, Coloplast A/S held its Annual General Meeting, at which EY Godkendt Revisionspartnerselskab was elected as Coloplast A/S’ auditors in line with the proposal from the Board of...

Vedlagt er vedtægter for Coloplast A/S som vedtaget på Coloplast A/S’ ordinære generalforsamling afholdt i dag den 7. december 2023.   For yderligere information, kontakt venligst ...

Articles of association for Coloplast A/S as adopted at the Annual General Meeting of Coloplast A/S held today, 7 December 2023 are enclosed. For further information, please contact ...

I dag, den 7. december 2023, har Coloplast A/S afholdt ordinær generalforsamling, hvor følgende beslutninger blev vedtaget: Årsrapporten for regnskabsåret 2022/23 blev godkendt. Forslag om...

Today, 7 December 2023, Cololast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2022/23 was approved.Distribution...